The Association of Clinical Research Professionals

Deepening Diversity: LGBTQIA+ Diversity in Clinical Research

Current efforts to improve diversity in clinical research fall short for the LGTBQIA+ population.

Date: July 10, 2024
Time: 12:00 – 1:00 PM ET

In this live webinar, expert panelists will discuss how sponsors can smooth the LGBTQIA+ patient journey for clinical trials, starting with gender-neutral protocols, how to make trial communication more inclusive, the FDA’s draft guidance on diversity plans and data collection, and the roles that sites/investigators can play.

Upon completion of this continuing education program, participants should be able to:

  • Know the basics — and limitations — of the FDA’s diversity plan requirements
  • Understand the importance of including LGBTQIA+ trial participants
  • Discover ways technology can capture SOGI (sexual orientation and gender identity) data


Fenwick Eckhardt (she/her)
Head of Diversity Strategy

Fenwick Eckhardt is a solutions consultant lead for clinical new product development at Citeline. She brings several years of experience working in the pharmaceutical and healthcare industry, working with small and large clients globally. Before joining Citeline, Fenwick worked at a boutique healthcare consultancy in London. In this role, she gained invaluable quantitative and qualitative experience conducting secondary market research for various major and rare diseases, proposal and report development, client relations, patient and KOL interviews, and behavioral analysis. Since joining the Citeline solution consulting team, Fenwick has focused on clients’ needs in the areas of new product development strategy, opportunity assessment, competitive intelligence, and product management. This work has covered projects across therapeutic areas, including oncology, autoimmune and inflammation, ophthalmology as well as rare diseases. Fenwick holds a bachelor of science degree in human physiology from Boston University and a master of science degree in international health management from Imperial College London.

Liam Paschall (he/him)
Former Associate Director, Learning and Development at Parexel, named one of LinkedIn’s Top 10 LGBTQIA+ Voices

Liam Paschall is a proud transgender man and a dedicated advocate and voice for the transgender community. With a passion deeply rooted in fostering understanding and inclusion, he has devoted his career to educating others on the nuances of trans experiences. Liam has been particularly active in the clinical research field, providing speaking engagements, training, and sharing his own experiences to increase awareness and improve healthcare for the transgender community. Through public speaking engagements, comprehensive workshops, and tailored training sessions, Liam works tirelessly to bridge gaps in knowledge and empathy. He has presented at various organizations, schools, medical facilities, and events, including the Drug Information Association’s annual event, CISCRP, National Medical Fellowships, Inc., Cisco, Red Hat, and more. Beyond educating, Liam is committed to actionable change, offering insights into how institutions and individuals can evolve toward genuine allyship. His work empowers his audience to become proactive participants in the journey toward equity and acceptance for transgender people everywhere.

Shir Netanel (she/her)
Associate Director, Patient Advocacy and Clinical Trial Advocacy, Global Medical Affairs Oncology
Johnson & Johnson

Shir Netanel is an accomplished leader in the field of healthcare advocacy and clinical trial management, currently serving as the Associate Director of Patient Advocacy and Clinical Trial Advocacy within the Global Medical Affairs Oncology division at Johnson & Johnson. With a background in biological sciences and a deep commitment to social justice, Shir has dedicated her career to promoting diversity, equity, and inclusion (DEI) to advance beyond industry standards when it comes to representation in clinical trials. At Johnson & Johnson, Shir leverages her lived experience as a queer individual to spearheaded initiatives that advocate for the inclusion of LGBTQIA+ folx in clinical research, determinedly working to break down barriers and promote understanding. In this role, she challenges traditional approaches to caring for queer communities by dispelling the stigma that associates the community solely with infectious diseases and mental health. Instead, Shir encourages people to view the work through a lens that recognizes how the SDoH impacts intersecting marginalized communities within sexual orientation, gender identity (SOGI) groups, and how they can profoundly impact health outcomes. A direct outcome of her efforts is the initiation of the LIBERTAS study – which is one of the first degendered and transgender inclusive prostate cancer clinical studies and serves as a foundational model for SGM inclusion in research.

Garo Kiledjian (he/him)
Founder and CEO
SGM Alliance

Garo Kiledjian is the Founder and CEO of SGM Alliance, a 501c3 nonprofit that focuses on educating and advocating for inclusive Sexual and Gender Minority (SGM) participation in clinical research, life sciences, and the evolution of healthcare. As someone passionate about people living with HIV, he also provides consulting for Trialogic, a Site Network for one of the largest global HIV healthcare providers. Having served in multilevel roles within administration, research, pharmacy, operations, and finance, Garo brings a versatile skill set to his leadership role. He also serves on the Membership Planning Committee for Society for Clinical Research Sites (SCRS) and is on the Executive Committee for the National LGBTQ Task Force—one of the oldest social advocacy groups that focuses on legislative and policy changes at the grassroots level in Washington, DC. He is passionate about DEI and offers a unique perspective on how the intersectionality of race and ethnicity overlap with gender and sexuality. Garo earned his Bachelor’s from UCLA and studied Leadership and Global Strategy at Woodbury’s Graduate School of Business.

Approved for 1.0 ACRP Contact Hours

The WebEx service used for ACRP webinars includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this webinar, you automatically consent to such recordings. If you do not wish to participate in the live recording, we recommend that you register to receive the link to the webinar replay.